Benzo[D]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors
US7939535B2 · kind B2 · utility
3Cited by
1References
59Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2009 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Nov 5, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of the general formula (I), having affinity and selectivity for the dopamine D3 receptors, their manufacture, pharmaceutical compositions containing them and their use for the therapeutic and/or prophylactic treatment of cognitive disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.